(3 Minutes Read)
Akdital Group, Morocco’s largest and only publicly traded private healthcare provider, has unveiled plans to expand into Saudi Arabia through a USD 1.4 billion strategic partnership with a group of undisclosed Saudi investors. The announcement, made on Tuesday, represents a major milestone in the company’s regional and international growth strategy.
According to Akdital’s official statement, the collaboration will focus on building and managing a comprehensive network of multi-specialty healthcare facilities across the Kingdom of Saudi Arabia. The initiative aims to leverage Akdital’s operational expertise and experience in integrated care systems to meet the growing demand for high-quality healthcare services in one of the Middle East’s most dynamic markets.
Under the terms of the agreement, approximately 25% of the total investment will be directed toward real estate development in partnership with local Saudi entities. Another 15% will be allocated to the acquisition of advanced medical equipment and related operational expenditures. The company did not disclose specific details on how the remaining 60% of the investment will be utilized but indicated it would support broader development and expansion goals within the partnership.
Dr. Rochdi Talib, Chair and Chief Executive Officer of Akdital Group, described the expansion as a “defining chapter” in the company’s international strategy. He emphasized that the partnership reflects Akdital’s commitment to “accelerating global growth and delivering world-class healthcare standards.” Talib added that the collaboration will allow Akdital to contribute its “expertise in hospital management, integrated healthcare, and patient-centered services” to Saudi Arabia’s rapidly evolving healthcare ecosystem.
Read Also;
https://trendsnafrica.com/saudi-arabia-and-morocco-give-special-thrust-to-security-cooperation/
Founded in 2011, Akdital has grown into Morocco’s leading private healthcare operator, managing a network of 41 hospitals and specialized clinics across the country. Its services cover a wide range of medical specialties, including oncology, cardiology, neurology, and critical care. Since its public listing on the Casablanca Stock Exchange in December 2022, Akdital has become one of the top 20 most valuable companies on the exchange, underscoring its strong performance and investor confidence.
This new Saudi venture marks Akdital’s first major international expansion, signaling its ambition to position itself as a key regional player in the healthcare sector across the Middle East and North Africa.